3pax

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="3pax" size="450" color="white" frame="true" align="right" spinBox="true" caption="3pax, resolution 2.4&Aring;" /> '''THE CATALYTIC FRAGMEN...)
Line 1: Line 1:
-
[[Image:3pax.gif|left|200px]]<br /><applet load="3pax" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:3pax.gif|left|200px]]<br /><applet load="3pax" size="350" color="white" frame="true" align="right" spinBox="true"
caption="3pax, resolution 2.4&Aring;" />
caption="3pax, resolution 2.4&Aring;" />
'''THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH 3-METHOXYBENZAMIDE'''<br />
'''THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH 3-METHOXYBENZAMIDE'''<br />
==Overview==
==Overview==
-
Inhibitors of poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30) are of, clinical interest because they have potential for improving radiation, therapy and chemotherapy of cancer. The refined binding structures of four, such inhibitors are reported together with the refined structure of the, unligated catalytic fragment of the enzyme. Following their design, all, inhibitors bind at the position of the nicotinamide moiety of the, substrate NAD+. The observed binding mode suggests inhibitor improvements, that avoid other NAD(+)-binding enzymes. Because the binding pocket of, NAD+ has been strongly conserved during evolution, the homology with, ADP-ribosylating bacterial toxins could be used to extend the bound, nicotinamide, which is marked by the inhibitors, to the full NAD+, molecule.
+
Inhibitors of poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30) are of clinical interest because they have potential for improving radiation therapy and chemotherapy of cancer. The refined binding structures of four such inhibitors are reported together with the refined structure of the unligated catalytic fragment of the enzyme. Following their design, all inhibitors bind at the position of the nicotinamide moiety of the substrate NAD+. The observed binding mode suggests inhibitor improvements that avoid other NAD(+)-binding enzymes. Because the binding pocket of NAD+ has been strongly conserved during evolution, the homology with ADP-ribosylating bacterial toxins could be used to extend the bound nicotinamide, which is marked by the inhibitors, to the full NAD+ molecule.
==About this Structure==
==About this Structure==
-
3PAX is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus] with 3MB as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=3PAX OCA].
+
3PAX is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus] with <scene name='pdbligand=3MB:'>3MB</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3PAX OCA].
==Reference==
==Reference==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Ruf, A.]]
[[Category: Ruf, A.]]
-
[[Category: Schulz, G.E.]]
+
[[Category: Schulz, G E.]]
[[Category: 3MB]]
[[Category: 3MB]]
[[Category: glycosyltransferase]]
[[Category: glycosyltransferase]]
Line 21: Line 21:
[[Category: transferase]]
[[Category: transferase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 19:54:43 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 19:10:33 2008''

Revision as of 17:10, 21 February 2008


3pax, resolution 2.4Å

Drag the structure with the mouse to rotate

THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH 3-METHOXYBENZAMIDE

Overview

Inhibitors of poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30) are of clinical interest because they have potential for improving radiation therapy and chemotherapy of cancer. The refined binding structures of four such inhibitors are reported together with the refined structure of the unligated catalytic fragment of the enzyme. Following their design, all inhibitors bind at the position of the nicotinamide moiety of the substrate NAD+. The observed binding mode suggests inhibitor improvements that avoid other NAD(+)-binding enzymes. Because the binding pocket of NAD+ has been strongly conserved during evolution, the homology with ADP-ribosylating bacterial toxins could be used to extend the bound nicotinamide, which is marked by the inhibitors, to the full NAD+ molecule.

About this Structure

3PAX is a Single protein structure of sequence from Gallus gallus with as ligand. Active as NAD(+) ADP-ribosyltransferase, with EC number 2.4.2.30 Full crystallographic information is available from OCA.

Reference

Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling., Ruf A, de Murcia G, Schulz GE, Biochemistry. 1998 Mar 17;37(11):3893-900. PMID:9521710

Page seeded by OCA on Thu Feb 21 19:10:33 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools